Journal article icon

Journal article

DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib (AZD6244; ARRY-142886) in wt BRAF advanced melanoma

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Oncology
Role:
Author
Expand authors...
Journal:
JOURNAL OF CLINICAL ONCOLOGY
Volume:
31
Issue:
15
Publication date:
2013-05-20
ISSN:
0732-183X
URN:
uuid:7f14318d-3d19-4db1-9315-cf84ed14c638
Source identifiers:
470551
Local pid:
pubs:470551

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP